Filtered By:
Source: Journal of Opioid Management
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 3701 results found since Jan 2013.
High-dose tramadol conversion to buprenorphine-naloxone
We report a case of a patient who was taking 1,000-1,250 mg of tramadol daily upon presentation to the clinic. She was originally prescribed 150 mg daily with escalation in dose and frequency over a 10-year period. The patient was converted to bupren-orphine-naloxone and has been successful in treatment of OUD for 1 year.PMID:37270427 | DOI:10.5055/jom.2023.0774
Source: Journal of Opioid Management - June 3, 2023 Category: Addiction Authors: Julienne K Kirk Charlotte T Boyd Lisa Cassidy-Vu Linda P McRae Heather E Strickland Ernest Blake Fagan Source Type: research
Opioids after a cesarean section: Prescribing, patient use, storage, and disposal practices
In this study, we observed 154 women who met inclusion criteria. Sixty women declined participation, and 15 could not recall the details of their opioid use. Of the 77 women who participated, most (97 percent) received oxycodone 5 mg tablets. About one-third of the women did not use any opioids, about one-third used all of their opioids, and the remainder used only a fraction of the pills prescribed. After sharing preliminary results with providers, they began prescribing fewer pills. Even then, only a fraction or none of the pills were used, and patients rarely required a renewal of pain prescriptions. We found only 1 per...
Source: Journal of Opioid Management - June 3, 2023 Category: Addiction Authors: Peter Yi Savion Johnson Amanda Nelli Padma Gulur Source Type: research
Clinical practice patterns of opioid prescribing by physicians -performing percutaneous spinal cord stimulation trials and implants
CONCLUSION: Based upon survey results and current literature, it is advisable to recommend or attempt opioid reduction before SCS and to not provide additional opioid for post-operative pain after trial lead insertion. Routine prescribing for the pain of the SCS implant beyond 7 days is not favored.PMID:37270425 | DOI:10.5055/jom.2023.0772
Source: Journal of Opioid Management - June 3, 2023 Category: Addiction Authors: Keisha Dodman Thomas T Simopoulos Lynn Kohan Jamal Hasoon Jatinder Gill Source Type: research
Variations of pain medication use for patients with acute extremity pain in an emergency department: A quality improvement project
CONCLUSION: There are patient, prescriber, and environment-specific characteristics that are associated with analgesic selection in an ED. Combination therapy had the greatest reduction in pain regardless of the two medications received.PMID:37270423 | DOI:10.5055/jom.2023.0770
Source: Journal of Opioid Management - June 3, 2023 Category: Addiction Authors: Rachael M Cardinal Frank D'Amico Elizabeth Cassidy Richard Heath Megan Baumgartner Source Type: research
New legislation in New Jersey reduced opioid use among trauma patients
CONCLUSION: Overall, opioid consumption was lower in 2018 without negatively affecting the quality of pain management. This suggests that the implementation of the new legislation has successfully reduced inpatient opioid use.PMID:37270420 | DOI:10.5055/jom.2023.0767
Source: Journal of Opioid Management - June 3, 2023 Category: Addiction Authors: Renay Durling-Grover Louis T DiFazio John M Adams Karen Kong Sara S Soliman Daniel Hakakian Keren Kaynan Rolando H Rolandelli Zoltan H Nemeth Source Type: research
Retrospectively evaluating trends in opioid prescriptions and medication-assisted treatment in a mid-Michigan region
CONCLUSION: Opioid prescribing guidelines have been effective in reducing opioid prescribing and increasing opioid prescription monitoring. MAT prescribing is low in 2019 and does not reflect a declining trend of opioid prescriptions during a public health crisis.PMID:37270419 | DOI:10.5055/jom.2023.0766
Source: Journal of Opioid Management - June 3, 2023 Category: Addiction Authors: Mariam Zunnu Rain Danielle Cremat Chin-I Cheng Alyson McClintock Juliette Perzhinsky Source Type: research
Comparison of the Centers for Disease Control (CDC) recommendations and the risk index for overdose or serious opioid-induced respiratory depression (RIOSORD) tool for guiding naloxone coprescribing
CONCLUSION: Coprescribing of naloxone is significantly underutilized in patients treated with opioid therapy for nonmalignant chronic pain and should not solely be based on total oral morphine milligram equivalents per day or concurrent benzodiazepine therapy. As risk assessment improves, consideration of other risk-conferring variables, such as gabapentinoids, skeletal muscle relaxants, and sleep hypnotics, should be considered.PMID:37270418 | DOI:10.5055/jom.2023.0765
Source: Journal of Opioid Management - June 3, 2023 Category: Addiction Authors: Christopher M Herndon Taylor R Kirby Kelsey J Madison Jessica L Kerr Source Type: research
High-dose tramadol conversion to buprenorphine-naloxone
We report a case of a patient who was taking 1,000-1,250 mg of tramadol daily upon presentation to the clinic. She was originally prescribed 150 mg daily with escalation in dose and frequency over a 10-year period. The patient was converted to bupren-orphine-naloxone and has been successful in treatment of OUD for 1 year.PMID:37270427 | DOI:10.5055/jom.2023.0774
Source: Journal of Opioid Management - June 3, 2023 Category: Addiction Authors: Julienne K Kirk Charlotte T Boyd Lisa Cassidy-Vu Linda P McRae Heather E Strickland Ernest Blake Fagan Source Type: research
Opioids after a cesarean section: Prescribing, patient use, storage, and disposal practices
In this study, we observed 154 women who met inclusion criteria. Sixty women declined participation, and 15 could not recall the details of their opioid use. Of the 77 women who participated, most (97 percent) received oxycodone 5 mg tablets. About one-third of the women did not use any opioids, about one-third used all of their opioids, and the remainder used only a fraction of the pills prescribed. After sharing preliminary results with providers, they began prescribing fewer pills. Even then, only a fraction or none of the pills were used, and patients rarely required a renewal of pain prescriptions. We found only 1 per...
Source: Journal of Opioid Management - June 3, 2023 Category: Addiction Authors: Peter Yi Savion Johnson Amanda Nelli Padma Gulur Source Type: research
Clinical practice patterns of opioid prescribing by physicians -performing percutaneous spinal cord stimulation trials and implants
CONCLUSION: Based upon survey results and current literature, it is advisable to recommend or attempt opioid reduction before SCS and to not provide additional opioid for post-operative pain after trial lead insertion. Routine prescribing for the pain of the SCS implant beyond 7 days is not favored.PMID:37270425 | DOI:10.5055/jom.2023.0772
Source: Journal of Opioid Management - June 3, 2023 Category: Addiction Authors: Keisha Dodman Thomas T Simopoulos Lynn Kohan Jamal Hasoon Jatinder Gill Source Type: research
Variations of pain medication use for patients with acute extremity pain in an emergency department: A quality improvement project
CONCLUSION: There are patient, prescriber, and environment-specific characteristics that are associated with analgesic selection in an ED. Combination therapy had the greatest reduction in pain regardless of the two medications received.PMID:37270423 | DOI:10.5055/jom.2023.0770
Source: Journal of Opioid Management - June 3, 2023 Category: Addiction Authors: Rachael M Cardinal Frank D'Amico Elizabeth Cassidy Richard Heath Megan Baumgartner Source Type: research
New legislation in New Jersey reduced opioid use among trauma patients
CONCLUSION: Overall, opioid consumption was lower in 2018 without negatively affecting the quality of pain management. This suggests that the implementation of the new legislation has successfully reduced inpatient opioid use.PMID:37270420 | DOI:10.5055/jom.2023.0767
Source: Journal of Opioid Management - June 3, 2023 Category: Addiction Authors: Renay Durling-Grover Louis T DiFazio John M Adams Karen Kong Sara S Soliman Daniel Hakakian Keren Kaynan Rolando H Rolandelli Zoltan H Nemeth Source Type: research
Retrospectively evaluating trends in opioid prescriptions and medication-assisted treatment in a mid-Michigan region
CONCLUSION: Opioid prescribing guidelines have been effective in reducing opioid prescribing and increasing opioid prescription monitoring. MAT prescribing is low in 2019 and does not reflect a declining trend of opioid prescriptions during a public health crisis.PMID:37270419 | DOI:10.5055/jom.2023.0766
Source: Journal of Opioid Management - June 3, 2023 Category: Addiction Authors: Mariam Zunnu Rain Danielle Cremat Chin-I Cheng Alyson McClintock Juliette Perzhinsky Source Type: research
Comparison of the Centers for Disease Control (CDC) recommendations and the risk index for overdose or serious opioid-induced respiratory depression (RIOSORD) tool for guiding naloxone coprescribing
CONCLUSION: Coprescribing of naloxone is significantly underutilized in patients treated with opioid therapy for nonmalignant chronic pain and should not solely be based on total oral morphine milligram equivalents per day or concurrent benzodiazepine therapy. As risk assessment improves, consideration of other risk-conferring variables, such as gabapentinoids, skeletal muscle relaxants, and sleep hypnotics, should be considered.PMID:37270418 | DOI:10.5055/jom.2023.0765
Source: Journal of Opioid Management - June 3, 2023 Category: Addiction Authors: Christopher M Herndon Taylor R Kirby Kelsey J Madison Jessica L Kerr Source Type: research
